StockNews.com began coverage on shares of Invitae (NYSE:NVTA – Free Report) in a research report report published on Friday morning. The brokerage issued a hold rating on the medical research company’s stock. Separately, The Goldman Sachs Group decreased their price objective on Invitae from $1.00 to $0.50 and set a sell rating for the company […]

Related Keywords

United States , Hong Kong , Canada , , Bridgefront Capital , Hong Kong Ltd , Goldman Sachs Group , Invitae Company Profile , Invitae Corporation , Free Report , Get Free Report , Investment Advisers , Financial Advisors , Kong Ltd , Engineers Gate Manager , Invitae Daily , Invitae , Nyse Nvta , Nvta , Medical , Initiated Coverage , Stocknews Com ,